Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv259.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian cancer,version 2.2020,NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(2):191–226.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15(1):23–34.
   PubMed Web of Science ®Google Scholar
• Maiorano BA, Maiorano MFP, Lorusso D, et al. Ovarian cancer in the era of immune checkpoint inhibitors: state of the art and future perspectives. Cancers (Basel). 2021;13(17):4438.
   PubMed Web of Science ®Google Scholar
• Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020;11(1):3801.
   PubMed Web of Science ®Google Scholar
• Doo DW, Norian LA, Arend RC. Checkpoint inhibitors in ovarian cancer: a review of preclinical data. Gynecol Oncol Rep. 2019;29:48–54.
   PubMed Web of Science ®Google Scholar
• Zou D, Wang Y, Wang M, et al. Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas. Bioengineered. 2021;12(1):496–506.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu J, Guo H, et al. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered. 2021;12(1):3159–3176.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang Y, Yang J, et al. Tumor microenvironment in ovarian cancer: function and therapeutic strategy. Front Cell Dev Biol. 2020;8:758.
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566.
   PubMed Web of Science ®Google Scholar
• Luo X, Xu J, Yu J, et al. Shaping immune responses in the tumor microenvironment of ovarian cancer. Front Immunol. 2021;12:692360.
   PubMed Web of Science ®Google Scholar
• Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy. 2020;16(1):3–17.
   PubMed Web of Science ®Google Scholar
• Wu Z, Oeck S, West AP, et al. Mitochondrial DNA stress signalling protects the nuclear genome. Nat Metab. 2019;1(12):1209–1218.
   PubMedGoogle Scholar
• Falkenberg M, Gaspari M, Rantanen A, et al. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet. 2002;31(3):289–294.
   PubMed Web of Science ®Google Scholar
• Bonekamp NA, Jiang M, Motori E, et al. High levels of TFAM repress mammalian mitochondrial DNA transcription in vivo. Life Sci Alliance. 2021;4(11):e202101034.
   PubMed Web of Science ®Google Scholar
• Kanki T, Ohgaki K, Gaspari M, et al. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol Cell Biol. 2004;24(22):9823–9834.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Arai M, Koitabashi N, et al. Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription. Cardiovasc Res. 2011;90(1):57–67.
   PubMed Web of Science ®Google Scholar
• Nicholas LM, Valtat B, Medina A, et al. Mitochondrial transcription factor B2 is essential for mitochondrial and cellular function in pancreatic beta-cells. Mol Metab. 2017;6(7):651–663.
   PubMed Web of Science ®Google Scholar
• West AP, Khoury-Hanold W, Staron M, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520(7548):553–557.
   PubMed Web of Science ®Google Scholar
• Bao D, Zhao J, Zhou X, et al. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression. Oncogene. 2019;38(25):5007–5020.
   PubMed Web of Science ®Google Scholar
• Perez-Trevino P, Velasquez M, Garcia N. Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165761.
   PubMed Web of Science ®Google Scholar
• Szczesny B, Marcatti M, Ahmad A, et al. Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells. Sci Rep. 2018;8(1):914.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Gyorffy B, Lanczky A, Szallasi Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012;19(2):197–208.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28(12):1248–1250.
   PubMed Web of Science ®Google Scholar
• Hu JM, Liu K, Liu JH, et al. CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma. Oncotarget. 2017;8(13):21526–21538.
   PubMedGoogle Scholar
• Yang M, Li Z, Ren M, et al. Stromal infiltration of tumor-associated macrophages conferring poor prognosis of patients with basal-like breast carcinoma. J Cancer. 2018;9(13):2308–2316.
   PubMed Web of Science ®Google Scholar
• Weng YS, Tseng HY, Chen YA, et al. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer. 2019;18(1):42.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Jauhari A, Baranov SV, Suofu Y, et al. Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J Clin Invest. 2021;131(9). DOI:10.1172/JCI150328.
   PubMed Web of Science ®Google Scholar
• Guo Y, Gu R, Gan D, et al. Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells. Cell Commun Signal. 2020;18(1):172.
   PubMed Web of Science ®Google Scholar
• Liu SY, Wei W, Yue H, et al. Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials. 2013;34(33):8291–8300.
   PubMed Web of Science ®Google Scholar
• Smith MP, Young H, Hurlstone A, et al. Differentiation of THP1 cells into macrophages for transwell co-culture assay with melanoma cells. Biol Protoc. 2015;5(21). DOI:10.21769/BioProtoc.1638
   Google Scholar
• Ashley N, Harris D, Poulton J. Detection of mitochondrial DNA depletion in living human cells using PicoGreen staining. Exp Cell Res. 2005;303(2):432–446.
   PubMed Web of Science ®Google Scholar
• Zhang JZ, Liu Z, Liu J, et al. Mitochondrial DNA induces inflammation and increases TLR9/NF-kappaB expression in lung tissue. Int J Mol Med. 2014;33(4):817–824.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Li D, Liu F, et al. Mitochondrial DNA plays an important role in lung injury induced by sepsis. J Cell Biochem. 2018.
   Google Scholar
• Echem C, Costa TJD, Oliveira V, et al. Mitochondrial DNA: a new driver for sex differences in spontaneous hypertension. Pharmacol Res. 2019;144:142–150.
   PubMed Web of Science ®Google Scholar
• Franco DG, Moretti IF, Marie SKN. Mitochondria transcription factor a: a putative target for the effect of Melatonin on U87MG malignant glioma cell line. Molecules. 2018;23(5):1129.
   PubMed Web of Science ®Google Scholar
• Geng X, Geng Z, Li H, et al. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-kappaB signalling in hepatocellular carcinoma. Liver Int. 2020;40(7):1756–1769.
   PubMed Web of Science ®Google Scholar
• Chang H, Li J, Luo Y, et al. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD(+) /SIRT3/HIF-1alpha signaling. J Gastroenterol Hepatol. 2021;36(10):2978–2988.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu VW, Xue WC, et al. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer. 2006;95(8):1087–1091.
   PubMed Web of Science ®Google Scholar
• Bao X, Zhang J, Huang G, et al. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis. 2021;12(2):215.
   PubMed Web of Science ®Google Scholar
• Dai W, Jiang L. Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer. Front Endocrinol (Lausanne). 2019;10:570.
   PubMed Web of Science ®Google Scholar
• Tanwar DK, Parker DJ, Gupta P, et al. Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients. Oncotarget. 2016;7(37):60021–60037.
   PubMedGoogle Scholar
• Braune J, Weyer U, Hobusch C, et al. IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity. J Immunol. 2017;198(7):2927–2934.
   PubMed Web of Science ®Google Scholar
• Kwon J, Bakhoum SF. The cytosolic DNA-Sensing cGAS-STING pathway in cancer. Cancer Discov. 2020;10(1):26–39.
   PubMed Web of Science ®Google Scholar
• West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17(6):363–375.
   PubMed Web of Science ®Google Scholar
• Dou Z, Ghosh K, Vizioli MG, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550(7676):402–406.
   PubMed Web of Science ®Google Scholar
• Park JH, Zhuang J, Li J, et al. p53 as guardian of the mitochondrial genome. FEBS Lett. 2016;590(7):924–934.
   PubMed Web of Science ®Google Scholar
• Blandino G, Valenti F, Sacconi A, et al. Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease. Semin Cell Dev Biol. 2020;98:105–117.
   PubMed Web of Science ®Google Scholar